Toku’s AI technology, CLAiR, provides fast, accurate, non-invasive cardiovascular disease (CVD) risk assessments using standard retinal images
News
How this treatment paradigm could change ocular cell therapy
Dr Baruch Kuppermann discusses interim results from the first in-human Phase 2 RIPPLE-1 Trial of a dexamethasone implant for diabetic macular oedema and retinal vein occlusion.
Robyn Guymer, MBBS, PhD, reported the Voyager study’s preliminary data at the 2024 Angiogenesis, Exudation, and Degeneration conference
EODM may be an ideal candidate for development of complement gene therapy due to the high-impact genetic variants
Researchers aimed to develop a translational map to understand how advanced imaging biomarkers manifest in typical diagnostic imaging
Kiora Pharmaceuticals and Théa Open Innovation will develop and commercialise KIO-301 for the treatment of inherited retinal diseases
Many options with one single Nd:YAG laser
Enhanced detection and diagnosis of common and severe diseases
An in-depth case study conversation
Standalone, minimally-invasive glaucoma treatments
The afternoon sessions begin after lunch and continue well into the evening at the Angiogenesis, Exudation, and Degeneration 2024 meeting
The one-day event will be held online Saturday, February 3, 2024, and is sponsored by the Bascom Palmer Eye Institute, University of Miami Health System
The partnership establishes a large-scale enrollment platform for research on MicroPulseTransscleral Laser Therapy (TLT)
Postoperative outcomes of the tissues obtained from these donors were satisfactory
Investigators advised that further studies should be conducted to understand more precisely the benefits and risks
Clinicians, researchers and stakeholders discussed establishing CVI diagnostic criteria, boosting awareness of CVI and creating a participant data registry
Euan Thomson, Head of the Ophthalmology Strategic Business Unit and Head of the Digital Business Unit at Carl Zeiss Meditec, discusses plans for the company's vitreoretinal surgery workflows following announcement of DORC acquisition
A strategic distribution partnership is expected to make Morrow’s eProgressive smart glasses available to consumers in the second quarter of 2024
The UK-based Rayner announced the acquisition will enhance its portfolio in the cataract surgery space
The findings come from a collaborative study between investigators at the Max Planck Institute of Psychiatry, Munich and the Department of Cognitive Sciences, University of California, Irvine
Dr Edmond has also served as president of the American Association for Paediatric Ophthalmology and Strabismus and an oral examiner for the American Board of Ophthalmology
The trial will use vision preservation as a primary outcome measure, according to Annexon
eSight, a wearable assistive technology company, produces comprehensive equipment for patients with over 20 ocular disorders
A reduction in clinical exposure has harmed student confidence, according to a questionnaire administered in the United Kingdom
The European Union approval applies to aflibercept 8 mg for treatment of nAMD and DME
Prevent Blindness will offer downloadable fact sheets, shareable social media graphics and educational videos for patients
The study illustrates efficacy of AVT06 as compared with aflibercept (Eylea) for neovascular age-related macular degeneration
Catch up on Modern Retina's top stories, and ones you may have missed in 2023
Advertisement
Advertisement
